Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
252
-
Total 13F shares, excl. options
-
85.4M
-
Shares change
-
+1.65M
-
Total reported value, excl. options
-
$4.27B
-
Value change
-
+$122M
-
Put/Call ratio
-
0.67
-
Number of buys
-
123
-
Number of sells
-
-104
-
Price
-
$49.97
Significant Holders of Biohaven Ltd. - Common Stock (BHVN) as of Q3 2024
291 filings reported holding BHVN - Biohaven Ltd. - Common Stock as of Q3 2024.
Biohaven Ltd. - Common Stock (BHVN) has 252 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.4M shares
of 106M outstanding shares and own 80.71% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.79M shares), BlackRock, Inc. (6.88M shares), STIFEL FINANCIAL CORP (6.51M shares), JANUS HENDERSON GROUP PLC (6.23M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (5.2M shares), FARALLON CAPITAL MANAGEMENT LLC (3.64M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.44M shares), STATE STREET CORP (3.26M shares), RP Management, LLC (2.94M shares), and Bellevue Group AG (2.04M shares).
This table shows the top 252 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.